Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CLINICAL PRACTICE

To choose or not? The value of discrete-choice experiments in rheumatology

Do you inform patients about risks and chances of success associated with different choices when treatment needs to be changed? This approach takes time and requires patient health literacy. Results from a discrete-choice experiment in scleroderma lung disease add to the debate on shared decision-making.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bruni, C. et al. Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment. Rheumatology https://doi.org/10.1093/rheumatology/keac126 (2022).

    Article  PubMed  Google Scholar 

  2. Aguiar, M. et al. Co-production of randomized clinical trials with patients: a case study in autologous hematopoietic stem cell transplant for patients with scleroderma. Trials 22, 611 (2021).

    Article  Google Scholar 

  3. Kato, M. et al. Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis. Sci. Rep. 9, 12062 (2019).

    Article  Google Scholar 

  4. Fernández-Codina, A., Walker, K. M. & Pope, J. E., Scleroderma Algorithm Group. Treatment algorithms for systemic sclerosis according to experts. Arthritis Rheumatol. 70, 1820–1828 (2018).

    Article  Google Scholar 

  5. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. 79, 685–699 (2020).

    Article  CAS  Google Scholar 

  6. Kowal-Bielecka, O. et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann. Rheum. Dis. 76, 1327–1339 (2017).

    Article  Google Scholar 

  7. Fleischmann, R., Jairath, V., Mysler, E., Nicholls, D. & Declerck, P. Nonmedical switching from originators to biosimilars: does the nocebo effect explain treatment failures and adverse events in rheumatology and gastroenterology? Rheumatol. Ther. 7, 35–64 (2020).

    Article  Google Scholar 

  8. The Decision Lab. The paradox of choice https://thedecisionlab.com/reference-guide/economics/the-paradox-of-choice (2022).

  9. Peters, E., Hart, P. S. & Fraenkel, L. Informing patients: the influence of numeracy, framing, and format of side effect information on risk perceptions. Med. Decis. Making. 31, 432–436 (2011).

    Article  Google Scholar 

  10. Harrison, M., Milbers, K., Hudson, M. & Bansback, N. Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments. BMJ Open 7, e014719 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Janet E. Pope.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pope, J.E. To choose or not? The value of discrete-choice experiments in rheumatology. Nat Rev Rheumatol 18, 433–434 (2022). https://doi.org/10.1038/s41584-022-00799-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-022-00799-z

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing